NoticiasCon ayuda de IA

iCardio.ai Joins Forces with SARC MedIQ to Enhance Cardiovascular Imaging Through AI Technology

iCardio.ai teams up with SARC MedIQ to enhance ultrasound interpretation using cutting-edge AI technology.

Mrudula Kulkarni
Por Mrudula Kulkarni
Editor Gerente - Pharma Now
11 sept 2024Updated Jun 26, 2025 · 2 min de lectura
iCardio.ai Joins Forces with SARC MedIQ to Enhance Cardiovascular Imaging Through AI Technology
https://hospitaltimes.co.uk/heart-in-the-machine-how-ai-is-transforming-cardiovascular-diagnosis/
Reportaje con ayuda de IA
Reviewed by Mrudula Kulkarni, Editor Gerente - Pharma Now

iCardio.ai has announced an exciting partnership with SARC MedIQ to enhance ultrasound image interpretation through advanced AI tools. By integrating iCardio.ai’s innovative AI technology into SARC MedIQ’s picture archiving and communication system (PACS), the collaboration aims to significantly improve the speed, accuracy, and efficiency of ultrasound diagnostics, particularly in cardiology.

Joseph Sokol, CEO of iCardio.ai, expressed enthusiasm about the partnership, noting, “SARC MedIQ's leadership is visionary, and their alignment with our mission makes them an ideal partner. AI is transforming medicine, and collaborations like this are propelling that shift forward. Our technology will empower clinicians and streamline the patient journey for better outcomes.”

This integration will make AI tools more accessible to clinicians, potentially transforming the diagnostic landscape for echocardiography by introducing new efficiencies. SARC MedIQ CEO Asaad Hakeem shared, “Incorporating iCardio.ai’s automated AI into our PACS system marks a significant step toward providing our users with enhanced tools for evaluating and diagnosing cardiovascular conditions."

Earlier this year, iCardio.ai partnered with Viz.ai to advance the rapid detection of aortic stenosis. iCardio.ai is dedicated to developing machine learning and deep learning algorithms for ultrasound analysis, while SARC MedIQ provides advanced, affordable healthcare solutions across Asia, North America, Africa, and Australia.

 

Mrudula Kulkarni
Written by
Mrudula Kulkarni
Editor Gerente - Pharma Now

My international experience as a researcher in Taiwan for three years has equipped me with a global perspective, enabling me to create content that resonates with an international audience.



Discussion

Cargando la conversación…

Más de Pharma News

Todos los artículos →